Clear aligners take on overbites: a kinder option for kids?
NCT ID NCT07420270
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study compared clear mandibular advancement aligners to traditional twin-block braces for correcting Class II Division 1 malocclusion (overbite) in 21 children aged 10-16. Participants were split into three groups and followed for 6 months. The goal was to see if the aligners could improve jaw and teeth alignment while being more comfortable and less noticeable.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mandibular Advancement Aligner (dental device)
- What this could lead to
- If successful, this could offer a more comfortable and less visible alternative to traditional braces for correcting overbites in children.
- What could go wrong
- This is a small, early-stage trial with only 21 participants, so results may not apply to everyone. The aligners may not work as well as standard appliances, and long-term effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
21 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
11 to 16 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Cervical Vertebrae Maturity: CS3-CS4 (Growing participants) * Chronological age: 10-14 years old (Female), 12-16 years old (Male) * Average or reduced lower anterior facial height (LAFH\<57%) * Mild to moderate skeletal Class II (4°\<ANB\<9°) * Retrognathic mandible (SNB\<78°) * Increased overjet (7mm≤OJ≤11mm) * Increased overbite by more than 30% * Molar relationship by more than ½ unit Class II bilaterally * Mild to moderate crowding Exclusion Criteria: * Participant with an anterior open bite * Participant with syndromic dentofacial anomalies * Participant with a previous history of orthodontic intervention * Participant with signs and symptoms of temporomandibular disorder * Participant with severe facial asymmetry (Deviation ≥4mm) * Not being consented to by both parents and participants * Poor quality of pre-treatment Lateral Cephalometric records * Participant with mental or physical disabilities affecting the ability to wear an appliance
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Growth modification are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Dentistry
Kuala Lumpur, Kuala Lumpur, 50603, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can viral markers predict who survives hepatitis b liver failure?
- Could a single shot replace daily HIV pills?
- Sleep hormone melatonin put to the test against lupus fatigue and inflammation
- Can early jaw treatment in children prevent major surgery later?
- Brain training may help prevent alcohol relapse after withdrawal
- Should older hepatitis b patients with normal ALT get antivirals? new study explores